ABSCF
Price
$1.26
Change
-$0.34 (-21.25%)
Updated
Jun 6 closing price
Capitalization
96.33M
ORGO
Price
$4.83
Change
+$0.15 (+3.21%)
Updated
Aug 26, 04:59 PM (EDT)
Capitalization
620.33M
71 days until earnings call
Interact to see
Advertisement

ABSCF vs ORGO

Header iconABSCF vs ORGO Comparison
Open Charts ABSCF vs ORGOBanner chart's image
AB Science, Paris
Price$1.26
Change-$0.34 (-21.25%)
Volume$400
Capitalization96.33M
Organogenesis Holdings
Price$4.83
Change+$0.15 (+3.21%)
Volume$8.91K
Capitalization620.33M
ABSCF vs ORGO Comparison Chart in %
Loading...
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSCF vs. ORGO commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSCF is a Hold and ORGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ABSCF: $1.26 vs. ORGO: $4.67)
Brand notoriety: ABSCF and ORGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ABSCF: 100% vs. ORGO: 67%
Market capitalization -- ABSCF: $96.33M vs. ORGO: $620.33M
ABSCF [@Pharmaceuticals: Generic] is valued at $96.33M. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $620.33M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSCF’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ABSCF’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ORGO is a better buy in the long-term than ABSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSCF’s TA Score shows that 2 TA indicator(s) are bullish while ORGO’s TA Score has 4 bullish TA indicator(s).

  • ABSCF’s TA Score: 2 bullish, 0 bearish.
  • ORGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABSCF is a better buy in the short-term than ORGO.

Price Growth

ABSCF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was +1.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.87%. For the same industry, the average monthly price growth was +11.08%, and the average quarterly price growth was +76.49%.

Reported Earning Dates

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.87% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORGO($620M) has a higher market cap than ABSCF($96.3M). ORGO YTD gains are higher at: 45.938 vs. ABSCF (40.000).
ABSCFORGOABSCF / ORGO
Capitalization96.3M620M16%
EBITDAN/A3.19M-
Gain YTD40.00045.93887%
P/E RatioN/A63.75-
RevenueN/A429M-
Total CashN/A73.1M-
Total DebtN/A40.8M-
FUNDAMENTALS RATINGS
ABSCF vs ORGO: Fundamental Ratings
ABSCF
ORGO
OUTLOOK RATING
1..100
3877
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
8438
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABSCF's Valuation (31) in the null industry is somewhat better than the same rating for ORGO (77) in the Financial Conglomerates industry. This means that ABSCF’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (94) in the Financial Conglomerates industry is in the same range as ABSCF (100) in the null industry. This means that ORGO’s stock grew similarly to ABSCF’s over the last 12 months.

ORGO's SMR Rating (94) in the Financial Conglomerates industry is in the same range as ABSCF (100) in the null industry. This means that ORGO’s stock grew similarly to ABSCF’s over the last 12 months.

ORGO's Price Growth Rating (38) in the Financial Conglomerates industry is somewhat better than the same rating for ABSCF (84) in the null industry. This means that ORGO’s stock grew somewhat faster than ABSCF’s over the last 12 months.

ORGO's P/E Growth Rating (11) in the Financial Conglomerates industry is significantly better than the same rating for ABSCF (100) in the null industry. This means that ORGO’s stock grew significantly faster than ABSCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABSCFORGO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
14%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 6 days ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ABSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DIGTF0.02N/A
N/A
Thruvision Group PLC
MEQYF144.67N/A
N/A
Mainstreet Equity Corp.
OCLDF12.25N/A
N/A
Orica Ltd.
MKKGY25.60-0.73
-2.77%
Merck KGaA
KROEF0.53-0.04
-6.48%
KR1 PLC

ABSCF and

Correlation & Price change

A.I.dvisor tells us that ABSCF and ALID have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABSCF and ALID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSCF
1D Price
Change %
ABSCF100%
N/A
ALID - ABSCF
16%
Poorly correlated
N/A
ORGO - ABSCF
5%
Poorly correlated
-4.50%
AGYTF - ABSCF
1%
Poorly correlated
N/A
ARSUF - ABSCF
1%
Poorly correlated
N/A
APNHF - ABSCF
1%
Poorly correlated
N/A
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.50%
ANIP - ORGO
47%
Loosely correlated
-0.76%
PRGO - ORGO
46%
Loosely correlated
-2.90%
ANIK - ORGO
32%
Poorly correlated
-5.39%
AMRX - ORGO
31%
Poorly correlated
-3.23%
ACET - ORGO
29%
Poorly correlated
-2.21%
More